Gastric cancer cells alter the immunosuppressive function of neutrophils

Hiramatsu,Soichiro; Tanaka,Hiroaki; Nishimura,Junya; Yamakoshi,Yoshihito; Sakimura,Chie; Tamura,Tatsuro; Toyokawa,Takahiro; Muguruma,Kazuya; Yashiro,Masakazu; Hirakawa,Kosei; Ohira,Masaichi

doi:10.3892/or.2019.7410

Gastric cancer cells alter the immunosuppressive function of neutrophils

Authors:
- Soichiro Hiramatsu
- Hiroaki Tanaka
- Junya Nishimura
- Yoshihito Yamakoshi
- Chie Sakimura
- Tatsuro Tamura
- Takahiro Toyokawa
- Kazuya Muguruma
- Masakazu Yashiro
- Kosei Hirakawa
- Masaichi Ohira
View Affiliations

Affiliations: Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Abeno‑ku, Osaka 545‑8585, Japan
Published online on: November 20, 2019 https://doi.org/10.3892/or.2019.7410
Pages: 251-259

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tumor‑associated neutrophils (TANs) have an immunosuppressive function and play an important role in tumor progression. However, the detailed mechanism is largely unknown. The present study investigated the immunosuppressive ability of TANs in gastric cancer. Tumor tissue culture supernatant (TTCS) and non‑tumor tissue culture supernatant (NTCS) were purified and added to neutrophils. Expression of programmed cell death ligand‑1 (PDL‑1), 7‑amino‑actinomycin D and human leukocyte antigen‑DR (HLA‑DR), and the levels of hydrogen peroxide (H2O2) were determined. Levels of programmed cell death‑1 (PD‑1) and CD25 were assessed in T cells co‑cultured with neutrophils. Furthermore, CD4+ T cells were co‑cultured with dendritic cells and neutrophils to examine their proliferation. CD15 and PD‑1 immunohistochemical staining was also performed to explore the positional relationship. The results revealed that the neutrophils incubated with TTCS showed upregulation of PDL‑1 expression, as well as a decreases in the ratio of apoptotic cells, expression of HLA‑DR, and levels of H2O2. CD4+ T cells co‑cultured with neutrophils conditioned with TTCS showed a decrease in proliferation, upregulation of PD‑1 expression, and downregulation of CD25 expression. IHC showed that PD‑1+ T cells formed clusters and TANs infiltrated around the clusters. In conclusion, neutrophils in gastric cancer tissue inhibit the proliferation of CD4+ T cells and may form a local immunosuppressive environment through the PD‑1/PDL‑1 pathway.

View Figures

View References

1	Ajani JA, Lee J, Sano T, Janjigian YY, Fan D and Song S: Gastric adenocarcinoma. Nat Rev Dis Primers. 3:170362017. View Article : Google Scholar : PubMed/NCBI
2	Mizrak Kaya D, Harada K, Shimodaira Y, Amlashi FG, Lin Q and Ajani JA: Advanced gastric adenocarcinoma: Optimizing therapy options. Expert Rev Clin Pharmacol. 10:263–271. 2017.PubMed/NCBI
3	Gu L, Chen M, Guo D, Zhu H, Zhang W, Pan J, Zhong X, Li X, Qian H and Wang X: PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis. PLoS One. 12:e01826922017. View Article : Google Scholar : PubMed/NCBI
4	Galdiero MR, Garlanda C, Jaillon S, Marone G and Mantovani A: Tumor associated macrophages and neutrophils in tumor progression. J Cell Physiol. 228:1404–1412. 2013. View Article : Google Scholar : PubMed/NCBI
5	Kataoka K, Deleersnijder A and Lordick F: Will molecular target agents enable the multidisciplinary treatment in stage IV gastric cancer? Eur J Surg Oncol. 43:1835–1845. 2017. View Article : Google Scholar : PubMed/NCBI
6	Hiramatsu S, Tanaka H, Nishimura J, Sakimura C, Tamura T, Toyokawa T, Muguruma K, Yashiro M, Hirakawa K and Ohira M: Neutrophils in primary gastric tumors are correlated with neutrophil infiltration in tumor-draining lymph nodes and the systemic inflammatory response. BMC Immunol. 19:132018. View Article : Google Scholar : PubMed/NCBI
7	Tokumoto M, Tanaka H, Ohira M, Go Y, Okita Y, Sakurai K, Toyokawa T, Kubo N, Muguruma K, Maeda K, et al: A positive correlation between neutrophils in regional lymph nodes and progression of gastric cancer. Anticancer Res. 34:7129–7136. 2014.PubMed/NCBI
8	Rakic A, Beaudry P and Mahoney DJ: The complex interplay between neutrophils and cancer. Cell Tissue Res. 371:517–529. 2018. View Article : Google Scholar : PubMed/NCBI
9	Aulakh GK: Neutrophils in the lung: ‘The first responders’. Cell Tissue Res. 371:577–588. 2018. View Article : Google Scholar : PubMed/NCBI
10	Rosales C, Lowell CA, Schnoor M and Uribe-Querol E: Neutrophils: Their role in innate and adaptive immunity 2017. J Immunol Res. 2017:97483452017. View Article : Google Scholar : PubMed/NCBI
11	Fridlender ZG and Albelda SM: Tumor-associated neutrophils: Friend or foe? Carcinogenesis. 33:949–955. 2012. View Article : Google Scholar : PubMed/NCBI
12	Hurt B, Schulick R, Edil B, El Kasmi KC and Barnett C Jr: Cancer-promoting mechanisms of tumor-associated neutrophils. Am J Surg. 214:938–944. 2017. View Article : Google Scholar : PubMed/NCBI
13	Ying HQ, Deng QW, He BS, Pan YQ, Wang F, Sun HL, Chen J, Liu X and Wang SK: The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients. Med Oncol. 31:3052014. View Article : Google Scholar : PubMed/NCBI
14	Miyamoto R, Inagawa S, Sano N, Tadano S, Adachi S and Yamamoto M: The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients. Eur J Surg Oncol. 44:607–612. 2018. View Article : Google Scholar : PubMed/NCBI
15	Feng JF, Huang Y and Chen QX: Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World J Surg Oncol. 12:582014. View Article : Google Scholar : PubMed/NCBI
16	Cortez-Retamozo V, Etzrodt M, Newton A, Rauch PJ, Chudnovskiy A, Berger C, Ryan RJ, Iwamoto Y, Marinelli B, Gorbatov R, et al: Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci USA. 109:24919–2496. 2012. View Article : Google Scholar
17	Zhou J, Nefedova Y, Lei A and Gabrilovich D: Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells. Semin Immunol. 35:19–28. 2018. View Article : Google Scholar : PubMed/NCBI
18	Pillay J, Tak T, Kamp VM and Koenderman L: Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: Similarities and differences. Cell Mol Life Sci. 70:3813–3827. 2013. View Article : Google Scholar : PubMed/NCBI
19	Nywening TM, Belt BA, Cullinan DR, Panni RZ, Han BJ, Sanford DE, Jacobs RC, Ye J, Patel AA, Gillanders WE, et al: Targeting both tumour-associated CXCR2(+) neutrophils and CCR2(+) macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma. Gut. 67:1112–1123. 2018. View Article : Google Scholar : PubMed/NCBI
20	Kato Y, Yashiro M, Noda S, Tendo M, Kashiwagi S, Doi Y, Nishii T, Matsuoka J, Fuyuhiro Y, Shinto O, et al: Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma. Br J Cancer. 102:898–907. 2010. View Article : Google Scholar : PubMed/NCBI
21	Immune suppression and infections. Keeping a balance. Mayo Clin Health Lett. 31:4–5. 2013.
22	Ostanin DV, Kurmaeva E, Furr K, Bao R, Hoffman J, Berney S and Grisham MB: Acquisition of antigen-presenting functions by neutrophils isolated from mice with chronic colitis. J Immunol. 188:1491–1502. 2012. View Article : Google Scholar : PubMed/NCBI
23	Cassatella MA: Human mature neutrophils as atypical APC. Blood. 129:1895–1896. 2017. View Article : Google Scholar : PubMed/NCBI
24	Singhal S, Bhojnagarwala PS, O'Brien S, Moon EK, Garfall AL, Rao AS, Quatromoni JG, Stephen TL, Litzky L, Deshpande C, et al: Origin and role of a subset of tumor-associated neutrophils with antigen-presenting cell features in early-stage human lung cancer. Cancer Cell. 30:120–135. 2016. View Article : Google Scholar : PubMed/NCBI
25	Wang TT, Zhao YL, Peng LS, Chen N, Chen W, Lv YP, Mao FY, Zhang JY, Cheng P, Teng YS, et al: Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway. Gut. 66:1900–1911. 2017. View Article : Google Scholar : PubMed/NCBI
26	Zhang X and Xu W: Neutrophils diminish T-cell immunity to foster gastric cancer progression: The role of GM-CSF/PD-L1/PD-1 signalling pathway. Gut. 66:1878–1880. 2017. View Article : Google Scholar : PubMed/NCBI
27	Sakimura C, Tanaka H, Okuno T, Hiramatsu S, Muguruma K, Hirakawa K, Wanibuchi H and Ohira M: B cells in tertiary lymphoid structures are associated with favorable prognosis in gastric cancer. J Surg Res. 215:74–82. 2017. View Article : Google Scholar : PubMed/NCBI
28	Tamura T, Ohira M, Tanaka H, Muguruma K, Toyokawa T, Kubo N, Sakurai K, Amano R, Kimura K, Shibutani M, et al: Programmed death-1 ligand-1 (PDL1) expression is associated with the prognosis of patients with stage II/III gastric cancer. Anticancer Res. 35:5369–5376. 2015.PubMed/NCBI
29	Abbas M, Steffens S, Bellut M, Becker JU, Großhennig A, Eggers H, Wegener G, Kuczyk MA, Kreipe HH, Grünwald V, et al: Do programmed death 1 (PD-1) and its ligand (PD-L1) play a role in patients with non-clear cell renal cell carcinoma? Med Oncol. 33:592016. View Article : Google Scholar : PubMed/NCBI
30	Hino R, Kabashima K, Kato Y, Yagi H, Nakamura M, Honjo T, Okazaki T and Tokura Y: Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma. Cancer. 116:1757–1766. 2010. View Article : Google Scholar : PubMed/NCBI
31	Bowers NL, Helton ES, Huijbregts RP, Goepfert PA, Heath SL and Hel Z: Immune suppression by neutrophils in HIV-1 infection: Role of PD-L1/PD-1 pathway. PLoS Pathog. 10:e10039932014. View Article : Google Scholar : PubMed/NCBI
32	Cheng Y, Li H, Deng Y, Tai Y, Zeng K, Zhang Y, Liu W, Zhang Q and Yang Y: Cancer-associated fibroblasts induce PDL1⁺ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma. Cell Death Dis. 9:4222018. View Article : Google Scholar : PubMed/NCBI
33	Galdiero MR, Varricchi G, Loffredo S, Mantovani A and Marone G: Roles of neutrophils in cancer growth and progression. J Leukoc Biol. 103:457–464. 2018. View Article : Google Scholar : PubMed/NCBI
34	Huang X, Pan Y, Ma J, Kang Z, Xu X, Zhu Y, Chen J, Zhang W, Chang W and Zhu J: Prognostic significance of the infiltration of CD163⁺ macrophages combined with CD66b⁺ neutrophils in gastric cancer. Cancer Med. 7:1731–1741. 2018. View Article : Google Scholar : PubMed/NCBI
35	Mishalian I, Bayuh R, Zolotarov L, Levy L, Singhal S, Albelda SM and Fridlender ZG: Tumor-associated neutrophils (TAN) develop protumorigenic properties during tumor progression. Cancer Immunol Immunother. 62:1745–1756. 2013. View Article : Google Scholar : PubMed/NCBI
36	Sagiv JY, Michaeli J, Assi S, Mishalian I, Kisos H, Levy L, Damti P, Lumbroso D, Polyansky L, Sionov RV, et al: Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 10:562–573. 2015. View Article : Google Scholar : PubMed/NCBI
37	Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS and Albelda SM: Polarization of tumor-associated neutrophil phenotype by TGF-beta: ‘N1’ versus ‘N2’ TAN. Cancer Cell. 16:183–194. 2009. View Article : Google Scholar : PubMed/NCBI